Page All:
Page 1
Medical Reimbursement Resource for Advanced Wound Care Now Available on Smith & Nephew Website
ST. PETERSBURG, Fla., March 26 -- The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (NYSE:SNN), is providing a web-based resource guide to medical reimbursement for its comprehensive line of advanced wound care products. The website is available now. Click here to view the site.
The site is an intuitively organized, easy-to-use resource. It includes PDF files listing HCPCS codes and Medicare fee schedules for Smith & Nephew NPWT, wound care, burn care, skin care, preps and solvents, IV site care, and surgery products. The site also features a "What's New" section, dedicated to highlighting breaking news in relevant medical reimbursement areas, and a "FAQs" section, which will be continuously updated to provide feedback on questions submitted by customers.
"Smith & Nephew is committed to supporting its customers as they navigate the reimbursement landscape," said Randall Carson, Director of Health Policy & Reimbursement at Smith & Nephew, North American Advanced Wound Management. "With questions and input from clinicians, we aim to maintain a robust, up-to-date, one-stop resource that clinicians can turn to often as a reference tool as well as for guidance on new or evolving areas of wound care reimbursement."
The website's address is http://global.smith-nephew.com/us/10209.htm. A link to the site may be found in the Resources section of Smith & Nephew's US Professional Home Page.
The wound care reimbursement site is part of http://www.smith-nephew.com/reimbursement, which includes reimbursement information for the total portfolio of Smith & Nephew products, including products from its endoscopy and orthopaedic divisions.
For more information about Smith & Nephew, please go to http://www.smith-nephew.com.
About Us
Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2009 were nearly $3.8 billion.
Forward-Looking Statements
This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Source: Smith & Nephew, Inc.
CONTACT: media, Steve DiMattia, Managing Director of EVC Group, Inc.,
+1-646-201-5445, for Smith & Nephew; or Tom Dugan, North American President of
Smith & Nephew Advanced Wound Management, +1-727-399-3766; or investors, Liz
Hewitt, Group Director, Corporate Affairs of Smith & Nephew, + 44 (0)
207-401-7646
Web Site: http://www.smith-nephew.com/
Medical Reimbursement Resource for Advanced Wound Care Now Available on Smith & Nephew Website
ST. PETERSBURG, Fla., March 26 -- The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (NYSE:SNN), is providing a web-based resource guide to medical reimbursement for its comprehensive line of advanced wound care products. The website is available now. Click here to view the site.
The site is an intuitively organized, easy-to-use resource. It includes PDF files listing HCPCS codes and Medicare fee schedules for Smith & Nephew NPWT, wound care, burn care, skin care, preps and solvents, IV site care, and surgery products. The site also features a "What's New" section, dedicated to highlighting breaking news in relevant medical reimbursement areas, and a "FAQs" section, which will be continuously updated to provide feedback on questions submitted by customers.
"Smith & Nephew is committed to supporting its customers as they navigate the reimbursement landscape," said Randall Carson, Director of Health Policy & Reimbursement at Smith & Nephew, North American Advanced Wound Management. "With questions and input from clinicians, we aim to maintain a robust, up-to-date, one-stop resource that clinicians can turn to often as a reference tool as well as for guidance on new or evolving areas of wound care reimbursement."
The website's address is http://global.smith-nephew.com/us/10209.htm. A link to the site may be found in the Resources section of Smith & Nephew's US Professional Home Page.
The wound care reimbursement site is part of http://www.smith-nephew.com/reimbursement, which includes reimbursement information for the total portfolio of Smith & Nephew products, including products from its endoscopy and orthopaedic divisions.
For more information about Smith & Nephew, please go to http://www.smith-nephew.com.
About Us
Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2009 were nearly $3.8 billion.
Forward-Looking Statements
This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Source: Smith & Nephew, Inc.
CONTACT: media, Steve DiMattia, Managing Director of EVC Group, Inc.,
+1-646-201-5445, for Smith & Nephew; or Tom Dugan, North American President of
Smith & Nephew Advanced Wound Management, +1-727-399-3766; or investors, Liz
Hewitt, Group Director, Corporate Affairs of Smith & Nephew, + 44 (0)
207-401-7646
Web Site: http://www.smith-nephew.com/